Cutaneous findings in patients with acromegaly and its relationship with concomitant endocrinopathies
İsa An,Filiz Cebeci Kahraman,Aslı Bilgiç,Aysun Şikar Aktürk,Hülya Albayrak,Demet Kartal,Salih Levent Çınar,Sezgi Sarıkaya Solak,Meltem Uslu,Hatice Erdi Şanlı,İncilay Kalay Yıldızhan,Mustafa Turhan Şahin,İlkin Zindanci,Sevil Savaş,Erhan Ayhan,Murat Cinel,Elif Nazlı Serin Ataş,Mustafa Aydemir,Alev Selek,Gülşah Elbüken,Sayid Shafi Zuhur,Züleyha Karaca,Buket Yılmaz Bülbül,Mustafa Ünübol,Özgür Demir,Zeliha Hekimsoy,Mazhar Tuna,Miray Asilsoy,Sedat Çetin
DOI: https://doi.org/10.1111/cen.15071
2024-05-08
Clinical Endocrinology
Abstract:Objectives Skin changes in acromegaly are often the first sign of the disease. The aim of this study was to describe the cutaneous findings in patients with acromegaly. In addition, a secondary aim was to investigate the possible association of these findings with remission status and concomitant endocrinopathies. Design, Patients, and Measurements In this prospective multicenter study, 278 patients over the age of 18 years with acromegaly who were followed up in 14 different tertiary healthcare institutions were included. These patients, who were followed up by the Endocrinology Department, were then referred to a dermatologist for dermatological examination. The frequency of skin lesions was investigated by detailed dermatologic examination. Dermatological diagnosis is reached by clinical, dermatological and/or dermoscopic examination, and rarely skin punch biopsy examinations in suspicious cases. The possible association of the skin findings between remitted and nonremitted patients and with concomitant endocrinopathies were evaluated. Results The most common skin findings in patients with acromegaly in our study were skin tags (52.5%), cherry angiomas (47.4%), seborrhoea (37%), varicose veins (33%), acneiform lesions (28.8%), hyperhidrosis (26.9%) and hypertrichosis (18.3%). Hypertrichosis was significantly more prevalent in patients nonremitted (p: .001), while xerosis cutis was significantly more prevalent in patients remitted (p: .001). The frequency of diabetes mellitus and hypothyroidism was significantly higher in patients with varicose veins and seborrhoeic keratosis than those without. Additionally, the coexistence of hypothyroidism, hyperthyroidism and galactorrhea was significantly higher in patients with Cherry angioma than in those without Cherry angioma (p‐values: .024, .034 and .027, respectively). The frequency of hypogonadism in those with xerosis cutis was significantly higher than in those without (p: .035). Conclusions Cutaneous androgenization findings such as skin tag, seborrhoea, acne and acanthosis nigricans are common in patients with acromegaly. Clinicians should be aware that skin findings associated with insulin resistance may develop in these patients. It can be said that the remission state in acromegaly has no curative effect on cutaneous findings. Only patients in remission were less likely to have hypertrichosis. This may allow earlier review of the follow‐up and treatment of acromegaly patients presenting with complaints of hypertrichosis. Additionally, it can be said that patients with skin findings such as cherry angioma may be predisposed to a second endocrinopathy, especially hypothyroidism. Including dermatology in a multidisciplinary perspective in acromegaly patient management would be beneficial to detect cutaneous findings earlier.
endocrinology & metabolism